Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 1, Pages 29-38Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI129203
Keywords
-
Categories
Funding
- NIH [HL061795, HL119145, HG007690, GM107618, HL125215, HL131787, HL139613, HL145420]
- American Heart Association [D700382, 19AIML34980000]
- National Scleroderma Foundation
Ask authors/readers for more resources
Advanced phenotyping of cardiovascular diseases has evolved with the application of high-resolution omics screening to populations enrolled in large-scale observational and clinical trials. This strategy has revealed that considerable heterogeneity exists at the genotype, endophenotype, and clinical phenotype levels in cardiovascular diseases, a feature of the most common diseases that has not been elucidated by conventional reductionism. In this discussion, we address genomic context and (endo)phenotypic heterogeneity, and examine commonly encountered cardiovascular diseases to illustrate the genotypic underpinnings of (endo)phenotypic diversity. We highlight the existing challenges in cardiovascular disease genotyping and phenotyping that can be addressed by the integration of big data and interpreted using novel analytical methodologies (network analysis). Precision cardiovascular medicine will only be broadly applied to cardiovascular patients once this comprehensive data set is subjected to unique, integrative analytical strategies that accommodate molecular and clinical heterogeneity rather than ignore or reduce it.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available